Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Greenwich LifeSciences (GLSI) Return on Capital Employed (2020 - 2025)

Greenwich LifeSciences filings provide 6 years of Return on Capital Employed readings, the most recent being 1062.18% for Q3 2025.

  • Quarterly Return on Capital Employed fell 87283.0% to 1062.18% in Q3 2025 from the year-ago period, while the trailing twelve-month figure was 1062.18% through Sep 2025, down 87283.0% year-over-year, with the annual reading at 401.85% for FY2024, 30802.0% down from the prior year.
  • Return on Capital Employed hit 1062.18% in Q3 2025 for Greenwich LifeSciences, up from 1448.59% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 7.69% in Q1 2021 and bottomed at 1448.59% in Q2 2025.
  • Average Return on Capital Employed over 5 years is 261.19%, with a median of 83.23% recorded in 2023.
  • The largest annual shift saw Return on Capital Employed crashed -527bps in 2021 before it crashed -123853bps in 2025.
  • Greenwich LifeSciences' Return on Capital Employed stood at 16.61% in 2021, then tumbled by -239bps to 56.23% in 2022, then plummeted by -113bps to 119.93% in 2023, then crashed by -293bps to 470.98% in 2024, then plummeted by -126bps to 1062.18% in 2025.
  • Per Business Quant, the three most recent readings for GLSI's Return on Capital Employed are 1062.18% (Q3 2025), 1448.59% (Q2 2025), and 844.7% (Q1 2025).